CancerIQ Launches Research Initiative to Quantify Downstream Value of Digitally Enabled Cancer Risk Programs

The "Validating Applications for Long-term Utility and Enhanced ROI" (VALUE) in Cancer Risk Programs Study aims to bring together health systems from across the country to advance understanding of the system-level financial value of genetics and genomics. CHICAGO, April 19, 2024...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: PDT Source Type: news